Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients

Cells. 2023 Aug 17;12(16):2084. doi: 10.3390/cells12162084.

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by an aberrant repair response with uncontrolled turnover of extracellular matrix involving mesenchymal cell phenotypes, where lung resident mesenchymal stem cells (LRMSC) have been supposed to have an important role. However, the contribution of LRMSC in lung fibrosis is not fully understood, and the role of LRMSC in IPF remains to be elucidated. Here, we performed transcriptomic and functional analyses on LRMSC isolated from IPF and control patients (CON). Both over-representation and gene set enrichment analyses indicated that oxidative phosphorylation is the major dysregulated pathway in IPF LRMSC. The most relevant differences in biological processes included complement activation, mesenchyme development, and aerobic electron transport chain. Compared to CON LRMSC, IPF cells displayed impaired mitochondrial respiration, lower expression of genes involved in mitochondrial dynamics, and dysmorphic mitochondria. These changes were linked to an impaired autophagic response and a lower mRNA expression of pro-apoptotic genes. In addition, IPF TGFβ-exposed LRMSC presented different expression profiles of mitochondrial-related genes compared to CON TGFβ-treated cells, suggesting that TGFβ reinforces mitochondrial dysfunction. In conclusion, these results suggest that mitochondrial dysfunction is a major event in LRMSC and that their occurrence might limit LRMSC function, thereby contributing to IPF development.

Keywords: apoptosis; idiopathic pulmonary fibrosis; lung resident mesenchymal stem cell; mitochondria; mitophagy; oxidative phosphorylation; transforming growth factor β.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy
  • Humans
  • Idiopathic Pulmonary Fibrosis* / genetics
  • Lung
  • Mesenchymal Stem Cells*
  • Mitochondria

Grants and funding

This research was funded by SEPAR, the Carlos III Health Institute (grant numbers PI16/02147 and PI19/01578), and grants and payments for research advice from Boehringer Ing, Ferrer, Roche, and Chiesi.